# Guardant Health (GH) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/GH
## Company Profile
- Ticker: GH
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Oncology
## Stock Data
- Close: 161.04 USD
- Market cap: 17260532757.929996 USD
- Last updated: 2026-09-03
## Business Overview
Guardant Health is a liquid-biopsy company focused on oncology diagnostics for screening, therapy selection, and disease monitoring.
## Why The Stock Is Moving

As of Sep 3, 2026, GH closed down 1.24% at $161.04. No new same-company headline was identified in the current news window.

## Geographic Base

Headquartered in the United States and listed on NASDAQ, Guardant sits in precision diagnostics.

## Business Model

The business depends on test adoption, reimbursement, clinical utility, and the expansion of liquid biopsy into more use cases.

## Landscape Position

Guardant is a leading oncology-diagnostics platform whose stock moves on adoption, reimbursement, and product performance.

## Future Catalysts

- Guardant Health's catalysts are Shield screening adoption, Reveal MRD traction, and any reimbursement or launch step that widens the oncology-diagnostics franchise. The company improves when screening and monitoring become more routine in clinical workflows.

## Recent News
- 2021-09-07 12:05 EST — [New Data at IASLC 2021 World Conference on Lung Cancer Demonstrates Advantages of Using the Guardant360® Liquid Biopsy Blood Test for Comprehensive Genomic Profiling in Advanced Lung Cancer](https://biopharmsignal.com/news/GH/new-data-at-iaslc-2021-world-conference-on-lung-cancer-demonstrates-advantages-o-55f8b540) — Source: Guardant Health
- 2021-09-02 20:05 EST — [Guardant Health to Participate in the Morgan Stanley Global Healthcare Conference](https://biopharmsignal.com/news/GH/guardant-health-to-participate-in-the-morgan-stanley-global-healthcare-conferenc-d8be08a9) — Source: Guardant Health
- 2020-09-01 20:03 EST — [Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference](https://biopharmsignal.com/news/GH/guardant-health-to-participate-in-morgan-stanley-2020-healthcare-conference-cb48af68) — Source: Guardant Health
- 2020-08-24 12:05 EST — [Guardant Health Receives FDA Emergency Use Authorization for its Guardant-19 Next Generation Sequencing-Based COVID-19 Test](https://biopharmsignal.com/news/GH/guardant-health-receives-fda-emergency-use-authorization-for-its-guardant-19-nex-ca3d8450) — Source: Guardant Health
- 2020-08-10 12:05 EST — [Guardant Health to Participate in Upcoming August Investor Conferences](https://biopharmsignal.com/news/GH/guardant-health-to-participate-in-upcoming-august-investor-conferences-507d0715) — Source: Guardant Health